Last reviewed · How we verify

Ipodate (iopodic acid)

Bracco · FDA-approved active Quality 25/100

Ipodate (generic name: iopodic acid) is a iopodic acid drug developed by Bracco. It is currently FDA-approved (first approved 1962) for Diagnostic aid.

Iopodic acid (Ipodate), marketed by Bracco, is a diagnostic aid used for visualizing the thyroid gland during imaging procedures, competing in a class with several established alternatives such as iodoxamic acid, adipiodone, iopanoic acid, iocetamic acid, and tyropanoate. Its key strength lies in its mechanism of action, which allows for effective thyroid visualization, supported by a key composition patent expiring in 2028. The primary risk to Ipodate's market position is the presence of multiple same-class competitors, some of which have been on the market since the 1950s, potentially limiting its market share growth.

At a glance

Generic nameiopodic acid
SponsorBracco
Drug classiopodic acid
Therapeutic areaOther
PhaseFDA-approved
First approval1962

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ipodate

What is Ipodate?

Ipodate (iopodic acid) is a iopodic acid drug developed by Bracco, indicated for Diagnostic aid.

What is Ipodate used for?

Ipodate is indicated for Diagnostic aid.

Who makes Ipodate?

Ipodate is developed and marketed by Bracco (see full Bracco pipeline at /company/bracco).

What is the generic name of Ipodate?

iopodic acid is the generic (nonproprietary) name of Ipodate.

What drug class is Ipodate in?

Ipodate belongs to the iopodic acid class. See all iopodic acid drugs at /class/iopodic-acid.

When was Ipodate approved?

Ipodate was first approved on 1962.

What development phase is Ipodate in?

Ipodate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing